Lupin inches up on incorporating wholly owned subsidiary

19 Mar 2025 Evaluate

Lupin is currently trading at Rs. 2041.40, up by 6.10 points or 0.30% from its previous closing of Rs. 2035.30 on the BSE.

The scrip opened at Rs. 2044.95 and has touched a high and low of Rs. 2046.50 and Rs. 2025.10 respectively. So far 2047 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2403.45 on 02-Jan-2025 and a 52 week low of Rs. 1493.75 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 2046.50 and Rs. 1950.85 respectively. The current market cap of the company is Rs. 93431.10 crore.

The promoters holding in the company stood at 46.95%, while Institutions and Non-Institutions held 46.79% and 6.26% respectively.

Lupin has incorporated wholly-owned subsidiary namely ‘Lupinlife Consumer Healthcare’. The company has received certificate of incorporation from Ministry of Corporate Affairs on March 18, 2025.  

Earlier, the company had received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2094.50 85.10 (4.24%)
03-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...